Skip to main content
Erschienen in: Supportive Care in Cancer 1/2017

24.08.2016 | Original Article

Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis

verfasst von: Albert J. Farias, India J. Ornelas, Sarah D. Hohl, Steven B. Zeliadt, Ryan N. Hansen, Christopher I. Li, Beti Thompson

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To better understand how physicians communicate with breast cancer patients about adjuvant endocrine therapy (AET), we explored, from the breast cancer patient’s perspective, dimensions of the patient-provider communication among women who were on active AET treatment.

Methods

Qualitative methods using semi-structured in-depth interviews were conducted with breast cancer patients (n = 22) who filled a prescription for AET in the previous 12 months. Interview questions aimed to elicit experiences with AET. We reviewed and coded interview transcripts using qualitative principles of inductive reasoning to identify concepts and themes from interview data.

Results

We grouped emergent themes into four major functions of physician-patient communication: (1) information exchange, (2) decision-making to take and continue AET, (3) enabling patient self-management and monitoring potential side effects, and (4) emotional support. Physicians exchanged information with patients in a way that they understood and enhanced patient’s health literacy regarding the benefits and knowledge of AET. Physicians empowered patients to make decisions about their care. Patients expressed trust and confidence in their physician which helped them seek care when needed. Patients reported a high degree of self-efficacy to self-manage AET and were continuing treatment despite potential side effects.

Conclusions

The results from our study suggest that women’s interactions and communication with their physician may be an important factor that contributes to the continued use of AET. Physicians who can communicate information about AET treatment benefits, purpose, and expectations in a way that patients can understand is a critical aspect of care that needs to be further studied.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Adisa AO, Lawal OO, Adesunkanmi AR (2008) Paradox of wellness and nonadherence among Nigerian women on breast cancer chemotherapy. J Cancer Res Ther 4:107–110CrossRefPubMed Adisa AO, Lawal OO, Adesunkanmi AR (2008) Paradox of wellness and nonadherence among Nigerian women on breast cancer chemotherapy. J Cancer Res Ther 4:107–110CrossRefPubMed
2.
Zurück zum Zitat American Cancer Society (2013) Breast Cancer Facts & Figures 2013–2014. In: Book breast cancer facts & figures 2013–2014. American Cancer Society, City American Cancer Society (2013) Breast Cancer Facts & Figures 2013–2014. In: Book breast cancer facts & figures 2013–2014. American Cancer Society, City
3.
Zurück zum Zitat Banning M (2012) Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care (Engl) 21:10–19CrossRef Banning M (2012) Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review. Eur J Cancer Care (Engl) 21:10–19CrossRef
4.
Zurück zum Zitat Bauer AM, Parker MM, Schillinger D, Katon W, Adler N, Adams AS, Moffet HH, Karter AJ (2014) Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE. J Gen Intern Med 29:1139–1147CrossRefPubMedPubMedCentral Bauer AM, Parker MM, Schillinger D, Katon W, Adler N, Adams AS, Moffet HH, Karter AJ (2014) Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE. J Gen Intern Med 29:1139–1147CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bernard H (2006) Research methods in anthropology: qualitative and quantitative approaches. AltaMira Press, Lanham, MD Bernard H (2006) Research methods in anthropology: qualitative and quantitative approaches. AltaMira Press, Lanham, MD
6.
Zurück zum Zitat Chlebowski RT, Kim J, Haque R (2014) Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res (Phila) 7:378–387CrossRef Chlebowski RT, Kim J, Haque R (2014) Adherence to endocrine therapy in breast cancer adjuvant and prevention settings. Cancer Prev Res (Phila) 7:378–387CrossRef
7.
Zurück zum Zitat Christensen AJ, Howren MB, Hillis SL, Kaboli P, Carter BL, Cvengros JA, Wallston KA, Rosenthal GE (2010) Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med 25:397–402CrossRefPubMedPubMedCentral Christensen AJ, Howren MB, Hillis SL, Kaboli P, Carter BL, Cvengros JA, Wallston KA, Rosenthal GE (2010) Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence. J Gen Intern Med 25:397–402CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R, (EBCTCG) EBCTCG (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784CrossRefPubMed Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R, (EBCTCG) EBCTCG (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784CrossRefPubMed
9.
Zurück zum Zitat Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322–328PubMed Demissie S, Silliman RA, Lash TL (2001) Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322–328PubMed
10.
Zurück zum Zitat DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62CrossRefPubMed DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64:52–62CrossRefPubMed
11.
Zurück zum Zitat Dicicco-Bloom B, Crabtree BF (2006) The qualitative research interview. Med Educ 40:314–321CrossRefPubMed Dicicco-Bloom B, Crabtree BF (2006) The qualitative research interview. Med Educ 40:314–321CrossRefPubMed
12.
Zurück zum Zitat Elder K, Ramamonjiarivelo Z, Wiltshire J, Piper C, Horn WS, Gilbert KL, Hullett S, Allison J (2012) Trust, medication adherence, and hypertension control in southern African American men. Am J Public Health 102:2242–2245CrossRefPubMedPubMedCentral Elder K, Ramamonjiarivelo Z, Wiltshire J, Piper C, Horn WS, Gilbert KL, Hullett S, Allison J (2012) Trust, medication adherence, and hypertension control in southern African American men. Am J Public Health 102:2242–2245CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M (2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27:1361–1367CrossRefPubMedPubMedCentral Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards A, Barry M (2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27:1361–1367CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Epstein R, Street RL (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda, MD NIH Publication No. 07-6225 Epstein R, Street RL (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. National Cancer Institute, Bethesda, MD NIH Publication No. 07-6225
15.
Zurück zum Zitat Goff SL, Mazor KM, Meterko V, Dodd K, Sabin J (2008) Patients’ beliefs and preferences regarding doctors’ medication recommendations. J Gen Intern Med 23:236–241CrossRefPubMedPubMedCentral Goff SL, Mazor KM, Meterko V, Dodd K, Sabin J (2008) Patients’ beliefs and preferences regarding doctors’ medication recommendations. J Gen Intern Med 23:236–241CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Green T (2009) Qualitative methods for Health Research. SAGE Publications Inc., Thousand Oaks, CA Green T (2009) Qualitative methods for Health Research. SAGE Publications Inc., Thousand Oaks, CA
17.
Zurück zum Zitat Grunfeld EA, Hunter MS, Sikka P, Mittal S (2005) Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59:97–102CrossRefPubMed Grunfeld EA, Hunter MS, Sikka P, Mittal S (2005) Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59:97–102CrossRefPubMed
18.
Zurück zum Zitat Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, MacLeod C, Mac Leod C, Tattersall MH (2005) Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol 23:1278–1288CrossRefPubMed Hagerty RG, Butow PN, Ellis PM, Lobb EA, Pendlebury SC, Leighl N, MacLeod C, Mac Leod C, Tattersall MH (2005) Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol 23:1278–1288CrossRefPubMed
19.
Zurück zum Zitat Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555–567CrossRefPubMed Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555–567CrossRefPubMed
20.
Zurück zum Zitat Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, Group AT (2005) Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62CrossRefPubMed Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, Group AT (2005) Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365:60–62CrossRefPubMed
21.
Zurück zum Zitat Howie JG, Heaney DJ, Maxwell M, Walker JJ, Freeman GK, Rai H (1999) Quality at general practice consultations: cross sectional survey. BMJ 319:738–743CrossRefPubMedPubMedCentral Howie JG, Heaney DJ, Maxwell M, Walker JJ, Freeman GK, Rai H (1999) Quality at general practice consultations: cross sectional survey. BMJ 319:738–743CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat DeCuir-Gunby J, Marshall PL, Mcculloch AW (2011) Developing and using a codebook for the analysis of interview data: an example from a professional development research project. Field Methods 23:136–155CrossRef DeCuir-Gunby J, Marshall PL, Mcculloch AW (2011) Developing and using a codebook for the analysis of interview data: an example from a professional development research project. Field Methods 23:136–155CrossRef
23.
Zurück zum Zitat Kaplan SH, Greenfield S, Ware JE (1989) Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 27:S110–S127CrossRefPubMed Kaplan SH, Greenfield S, Ware JE (1989) Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care 27:S110–S127CrossRefPubMed
24.
Zurück zum Zitat Kelly M, McCarthy S, Sahm LJ (2014) Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature. Eur J Clin Pharmacol 70:1423–1431CrossRefPubMed Kelly M, McCarthy S, Sahm LJ (2014) Knowledge, attitudes and beliefs of patients and carers regarding medication adherence: a review of qualitative literature. Eur J Clin Pharmacol 70:1423–1431CrossRefPubMed
25.
Zurück zum Zitat MacQueen KM, McLellan E, Kay K, Milstein B (1998) Codebook development for team-based qualitative analysis. Cultural Anthropological Methods 10:31–36 MacQueen KM, McLellan E, Kay K, Milstein B (1998) Codebook development for team-based qualitative analysis. Cultural Anthropological Methods 10:31–36
26.
Zurück zum Zitat Miles MB, Huberman AM (1994) Qualitative data analysis: an expanded sourcebook. Sage Publications, Thousand Oaks, CA Miles MB, Huberman AM (1994) Qualitative data analysis: an expanded sourcebook. Sage Publications, Thousand Oaks, CA
27.
Zurück zum Zitat National Comprehensive Cancer Network (2014) NCCN clinical practice guidelines in oncology (NCCN Guidelines®), breast cancer. In: Book NCCN clinical practice guidelines in oncology (NCCN Guidelines®), Breast Cancer, City. National Comprehensive Cancer Network (2014) NCCN clinical practice guidelines in oncology (NCCN Guidelines®), breast cancer. In: Book NCCN clinical practice guidelines in oncology (NCCN Guidelines®), Breast Cancer, City.
28.
Zurück zum Zitat Noureldin M, Plake KS, Morrow DG, Tu W, Wu J, Murray MD (2012) Effect of health literacy on drug adherence in patients with heart failure. Pharmacotherapy 32:819–826CrossRefPubMed Noureldin M, Plake KS, Morrow DG, Tu W, Wu J, Murray MD (2012) Effect of health literacy on drug adherence in patients with heart failure. Pharmacotherapy 32:819–826CrossRefPubMed
29.
Zurück zum Zitat O’Hair D, Villagran MM, Wittenberg E, Brown K, Ferguson M, Hall HT, Doty T (2003) Cancer survivorship and agency model: implications for patient choice, decision making, and influence. Health Commun 15:193–202CrossRefPubMed O’Hair D, Villagran MM, Wittenberg E, Brown K, Ferguson M, Hall HT, Doty T (2003) Cancer survivorship and agency model: implications for patient choice, decision making, and influence. Health Commun 15:193–202CrossRefPubMed
30.
Zurück zum Zitat Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556–562CrossRefPubMed Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556–562CrossRefPubMed
31.
Zurück zum Zitat Polinski JM, Kesselheim AS, Frolkis JP, Wescott P, Allen-Coleman C, Fischer MA (2014) A matter of trust: patient barriers to primary medication adherence. Health Educ Res 29:755–763CrossRefPubMed Polinski JM, Kesselheim AS, Frolkis JP, Wescott P, Allen-Coleman C, Fischer MA (2014) A matter of trust: patient barriers to primary medication adherence. Health Educ Res 29:755–763CrossRefPubMed
32.
Zurück zum Zitat Rosenberg HJ, Rosenberg SD, Ernstoff MS, Wolford GL, Amdur RJ, Elshamy MR, Bauer-Wu SM, Ahles TA, Pennebaker JW (2002) Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 32:37–53CrossRefPubMed Rosenberg HJ, Rosenberg SD, Ernstoff MS, Wolford GL, Amdur RJ, Elshamy MR, Bauer-Wu SM, Ahles TA, Pennebaker JW (2002) Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med 32:37–53CrossRefPubMed
33.
Zurück zum Zitat Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman AB (2003) Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 163:83–90CrossRefPubMed Schillinger D, Piette J, Grumbach K, Wang F, Wilson C, Daher C, Leong-Grotz K, Castro C, Bindman AB (2003) Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med 163:83–90CrossRefPubMed
34.
Zurück zum Zitat Schwartzberg LS, Cobb P, Senecal F, Henry D, Kulig K, Walker MS, Houts AC, Stepanski EJ (2009) Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer. Breast 18:78–83CrossRefPubMed Schwartzberg LS, Cobb P, Senecal F, Henry D, Kulig K, Walker MS, Houts AC, Stepanski EJ (2009) Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer. Breast 18:78–83CrossRefPubMed
35.
Zurück zum Zitat Sedjo RL, Devine S (2011) Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat 125:191–200CrossRefPubMed Sedjo RL, Devine S (2011) Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat 125:191–200CrossRefPubMed
36.
Zurück zum Zitat Street RL, Ronald M (2008) Key interpersonal functions and health outcomes: lessons from theory and research on clinician-patient communication health behavior and health education: theory, research, and practice. Jossey-Bass, San Francisco, CA, pp. 237–269 Street RL, Ronald M (2008) Key interpersonal functions and health outcomes: lessons from theory and research on clinician-patient communication health behavior and health education: theory, research, and practice. Jossey-Bass, San Francisco, CA, pp. 237–269
37.
38.
Zurück zum Zitat Ward MM, Sundaramurthy S, Lotstein D, Bush TM, Neuwelt CM, Street RL (2003) Participatory patient-physician communication and morbidity in patients with systemic lupus erythematosus. Arthritis Rheum 49:810–818CrossRefPubMed Ward MM, Sundaramurthy S, Lotstein D, Bush TM, Neuwelt CM, Street RL (2003) Participatory patient-physician communication and morbidity in patients with systemic lupus erythematosus. Arthritis Rheum 49:810–818CrossRefPubMed
39.
Zurück zum Zitat Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer WM, Group BOoATBS (2010) Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 181:566–577CrossRefPubMed Wilson SR, Strub P, Buist AS, Knowles SB, Lavori PW, Lapidus J, Vollmer WM, Group BOoATBS (2010) Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 181:566–577CrossRefPubMed
40.
Zurück zum Zitat Wouters H, Stiggelbout AM, Bouvy ML, Maatman GA, Van Geffen EC, Vree R, Nortier JW, Van Dijk L (2014) Endocrine therapy for breast cancer: assessing an array of women’s treatment experiences and perceptions, their perceived self-efficacy and nonadherence Clin Breast Cancer 14: 460–467.e462 Wouters H, Stiggelbout AM, Bouvy ML, Maatman GA, Van Geffen EC, Vree R, Nortier JW, Van Dijk L (2014) Endocrine therapy for breast cancer: assessing an array of women’s treatment experiences and perceptions, their perceived self-efficacy and nonadherence Clin Breast Cancer 14: 460–467.e462
Metadaten
Titel
Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis
verfasst von
Albert J. Farias
India J. Ornelas
Sarah D. Hohl
Steven B. Zeliadt
Ryan N. Hansen
Christopher I. Li
Beti Thompson
Publikationsdatum
24.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3389-6

Weitere Artikel der Ausgabe 1/2017

Supportive Care in Cancer 1/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.